[
  {
    "ts": null,
    "headline": "REGENXBIO Inc. (RGNX): A Bull Case Theory",
    "summary": "We came across a bullish thesis on REGENXBIO Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on RGNX. REGENXBIO Inc.’s share was trading at $13.76 as of January 15th. REGENXBIO is a clinical-stage biotechnology company focused on the development of gene therapies built on its proprietary NAV Technology platform, leveraging AAV8 and […]",
    "url": "https://finnhub.io/api/news?id=61c24102e89bacf66e4168e5b69ee6489cac3c5036262337a684bc0b2f5d215a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768861219,
      "headline": "REGENXBIO Inc. (RGNX): A Bull Case Theory",
      "id": 138181354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on REGENXBIO Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on RGNX. REGENXBIO Inc.’s share was trading at $13.76 as of January 15th. REGENXBIO is a clinical-stage biotechnology company focused on the development of gene therapies built on its proprietary NAV Technology platform, leveraging AAV8 and […]",
      "url": "https://finnhub.io/api/news?id=61c24102e89bacf66e4168e5b69ee6489cac3c5036262337a684bc0b2f5d215a"
    }
  },
  {
    "ts": null,
    "headline": "Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback",
    "summary": "AbbVie’s recent performance and what it might mean for investors AbbVie (ABBV) has seen its share price record a 1 day return of about a 1.1% decline, with pullbacks of roughly 2.6% over the past week and 5.5% over the past month. See our latest analysis for AbbVie. While AbbVie’s recent share price has eased, with a 90-day share price return of a 7.36% decline and a year-to-date return of a 6.52% decline, its 1-year total shareholder return of 29.13% and 5-year total shareholder return of...",
    "url": "https://finnhub.io/api/news?id=4c47391cc86fd419b5bedd719af00910db49011e370df9ef92f3d18fe1224abb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768846094,
      "headline": "Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback",
      "id": 138180266,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie’s recent performance and what it might mean for investors AbbVie (ABBV) has seen its share price record a 1 day return of about a 1.1% decline, with pullbacks of roughly 2.6% over the past week and 5.5% over the past month. See our latest analysis for AbbVie. While AbbVie’s recent share price has eased, with a 90-day share price return of a 7.36% decline and a year-to-date return of a 6.52% decline, its 1-year total shareholder return of 29.13% and 5-year total shareholder return of...",
      "url": "https://finnhub.io/api/news?id=4c47391cc86fd419b5bedd719af00910db49011e370df9ef92f3d18fe1224abb"
    }
  },
  {
    "ts": null,
    "headline": "The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever",
    "summary": "All three of these healthcare giants are leaders in their niches.",
    "url": "https://finnhub.io/api/news?id=e9939cfef0c4f38db1d0b06d2ca2ed24229091e544d012753c94937eb114cc79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768838820,
      "headline": "The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever",
      "id": 138178998,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "All three of these healthcare giants are leaders in their niches.",
      "url": "https://finnhub.io/api/news?id=e9939cfef0c4f38db1d0b06d2ca2ed24229091e544d012753c94937eb114cc79"
    }
  },
  {
    "ts": null,
    "headline": "3 “Forever Stocks” to Hold When the Market Won’t Sit Still",
    "summary": "Chevron, Colgate-Palmolive, and Merck highlight how dividends, durable businesses, and long-term growth drivers can support a buy-and-hold investment strategy",
    "url": "https://finnhub.io/api/news?id=3b3e95d23d25fd53b61c2a12d84ff5a6bdff14918a1dbc8fbf41b7fdfe571858",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768836660,
      "headline": "3 “Forever Stocks” to Hold When the Market Won’t Sit Still",
      "id": 138187454,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Chevron, Colgate-Palmolive, and Merck highlight how dividends, durable businesses, and long-term growth drivers can support a buy-and-hold investment strategy",
      "url": "https://finnhub.io/api/news?id=3b3e95d23d25fd53b61c2a12d84ff5a6bdff14918a1dbc8fbf41b7fdfe571858"
    }
  },
  {
    "ts": null,
    "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
    "summary": "Income investors can rely on these stocks.",
    "url": "https://finnhub.io/api/news?id=42b150a77563a93212d7323e14357a49e4822afb1632e7a79f3a44ef7ca19228",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768813500,
      "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
      "id": 138175734,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Income investors can rely on these stocks.",
      "url": "https://finnhub.io/api/news?id=42b150a77563a93212d7323e14357a49e4822afb1632e7a79f3a44ef7ca19228"
    }
  },
  {
    "ts": null,
    "headline": "The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie",
    "summary": "These stocks sport dividend yields ranging from 2.9% to 5.5%.",
    "url": "https://finnhub.io/api/news?id=16b05537172fffce3201876d56faabe6d2e0b600028935b7046d5a7c42325103",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768801800,
      "headline": "The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie",
      "id": 138174480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "These stocks sport dividend yields ranging from 2.9% to 5.5%.",
      "url": "https://finnhub.io/api/news?id=16b05537172fffce3201876d56faabe6d2e0b600028935b7046d5a7c42325103"
    }
  }
]